Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Top Cited Papers
- 18 December 2008
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 8 (2), 141-150
- https://doi.org/10.1016/s1474-4422(08)70267-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) studyAnnals of Neurology, 2006
- Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)Stroke, 2006
- Perfusion-CT Assessment of Infarct Core and PenumbraStroke, 2006
- The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)Stroke, 2005
- Vampire Bat Salivary Plasminogen Activator (Desmoteplase)Stroke, 2003
- Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imagingAnnals of Neurology, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985